The closed-loop system dynamically self-adjusts DBS therapy to individual brain activity in real time, providing personalized ...
The FDA approved adaptive deep brain stimulation (DBS) technology (BrainSense adaptive DBS and BrainSense electrode ...
T here is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...
New research shows people in specific Polynesian communities have a much higher rate of a form of Parkinson’s disease ...
Medtronic said Monday the U.S. Food and Drug Administration has approved an adaptive brain-stimulation device as a treatment ...
Medtronic has received approval from the FDA for BrainSense, its aDBS therapy for patients living with Parkinson’s disease.
Starting today, people with Parkinson's disease will have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology.
New research finds chronic pain is five times more common in patients with Parkinson’s disease compared to age-matched ...
Medtronic said the Food and Drug Administration approved a brain stimulation system for people afflicted with Parkinson's disease.
After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...